furosemide has been researched along with Bone Diseases, Metabolic in 7 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, EA | 1 |
| White, AM | 1 |
| Liu, P | 1 |
| Yee, K | 1 |
| Waber, B | 1 |
| Monk, HM | 1 |
| Zhang, H | 1 |
| Serra Soler, G | 1 |
| García Fernández, H | 1 |
| Quevedo Juanals, J | 1 |
| Argüelles Jiménez, I | 1 |
| Carrillo García, P | 1 |
| Farley, JF | 1 |
| Cline, RR | 1 |
| Hansen, RA | 1 |
| Tokumoto, T | 1 |
| Tanabe, K | 1 |
| Toma, H | 1 |
| Akiba, T | 1 |
| Weger, W | 1 |
| Kotanko, P | 1 |
| Weger, M | 1 |
| Deutschmann, H | 1 |
| Skrabal, F | 1 |
| Udelsman, R | 1 |
| Atkinson, SA | 1 |
| Shah, JK | 1 |
| McGee, C | 1 |
| Steele, BT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Calciuric Effect and Cyclic Parenteral Nutrition in Preterm Infants[NCT00711763] | 1 participants (Actual) | Observational | 2008-07-31 | Terminated (stopped due to failure to recruit more patients and lack of supporting personnel.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for furosemide and Bone Diseases, Metabolic
| Article | Year |
|---|---|
[Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].
Topics: Bone Density; Bone Diseases, Metabolic; Calcitonin; Chronic Disease; Diphosphonates; Epoxy Compounds | 2004 |
Primary hyperparathyroidism.
Topics: Adenocarcinoma; Adenoma; Bone Diseases, Metabolic; Calcitonin; Diagnostic Imaging; Diphosphonates; D | 2001 |
5 other studies available for furosemide and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Determinants of Severe Metabolic Bone Disease in Very Low-Birth-Weight Infants with Severe Bronchopulmonary Dysplasia Admitted to a Tertiary Referral Center.
Topics: Birth Weight; Bone Diseases, Metabolic; Bronchopulmonary Dysplasia; Comorbidity; Female; Furosemide; | 2016 |
[Parathyroid crisis due to a cystic parathyroid adenoma].
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Colectomy; Colonic Diseases; | 2011 |
Resorptive drug use among community-dwelling women in Minnesota.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Bone Diseases, Metabolic; Bone Resorption; Calcitonin; Cro | 2004 |
Prevalence and characterization of renal tubular acidosis in patients with osteopenia and osteoporosis and in non-porotic controls.
Topics: Acidosis, Renal Tubular; Acids; Adult; Aged; Bone Density; Bone Diseases, Metabolic; Female; Furosem | 2000 |
Mineral excretion in premature infants receiving various diuretic therapies.
Topics: Birth Weight; Bone Diseases, Metabolic; Diuretics; Drug Therapy, Combination; Female; Furosemide; Hu | 1988 |